Stay updated on Daratumumab for MRD Reappearance in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.

Latest updates to the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the page. The funding/status banner about government operations was deleted.SummaryDifference0.4%

- Check20 days agoChange DetectedA new top notice about government funding lapse and NIH Clinical Center operation status was added, with guidance to visit opm.gov for updates. Related topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were added, and the revision version changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedAdded glossary display, 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed core term 'Multiple Myeloma' and related topics such as 'MedlinePlus Genetics', and updated QC-related labels, with a revision history change from v3.3.4 to v3.4.0.SummaryDifference0.4%

- Check35 days agoChange DetectedAdded 'Multiple myeloma' as a topic. A Related topics section now links to MedlinePlus Genetics.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no other changes to the study page content are visible.SummaryDifference0.1%

- Check56 days agoChange DetectedRelated topics entries 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the page.SummaryDifference0.2%

Stay in the know with updates to Daratumumab for MRD Reappearance in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.